Agios (AGIO) CMO logs tax-driven share sales and major new equity awards
Rhea-AI Filing Summary
AGIOS PHARMACEUTICALS Chief Medical Officer Sarah Gheuens reported multiple equity transactions. On March 2, 2026, she exercised restricted stock units into common shares and sold a total of 4,055 common shares at $28.96 per share to cover tax withholding obligations under pre-set Rule 10b5-1 instructions. Following these transactions, she directly held 74,406 shares of common stock. On March 1, 2026, she also received equity compensation grants of 14,000 and 22,000 restricted stock units and 52,000 stock options, all vesting over multi-year schedules beginning in March 2027.
Positive
- None.
Negative
- None.
Insights
Routine equity grants and tax sales; no thesis-changing signal.
Chief Medical Officer Sarah Gheuens exercised restricted stock units into common stock and reported open-market sales of 4,055 shares at $28.96 on March 2, 2026. Footnotes state these sales were to satisfy tax withholding obligations under durable, automatic Rule 10b5-1 instructions.
On March 1, 2026, she received substantial equity compensation: 14,000 and 22,000 restricted stock units and 52,000 stock options, all vesting over several years starting on March 1, 2027. This mix of awards and tax-driven sales is typical for senior executives and does not, by itself, indicate a directional view on the company.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted stock units | 4,000 | $0.00 | -- |
| Exercise | Restricted stock units | 5,666 | $0.00 | -- |
| Exercise | Restricted stock units | 4,000 | $0.00 | -- |
| Exercise | Common stock | 4,000 | $0.00 | -- |
| Sale | Common stock | 1,187 | $28.96 | $34K |
| Exercise | Common stock | 5,666 | $0.00 | -- |
| Sale | Common stock | 1,681 | $28.96 | $49K |
| Exercise | Common stock | 4,000 | $0.00 | -- |
| Sale | Common stock | 1,187 | $28.96 | $34K |
| Grant/Award | Restricted stock units | 14,000 | $0.00 | -- |
| Grant/Award | Restricted stock units | 22,000 | $0.00 | -- |
| Grant/Award | Stock options (right to buy) | 52,000 | $0.00 | -- |
Footnotes (1)
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments. This option was granted on March 1, 2026. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter. The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
